Will UK patients get access to novel drugs?
NHS England, NICE, Quintiles IMS Market Access Summit, quintilesIMS, UK market access
0 Comment
Access to new medicines is not high up the list of priorities for NHS England, but pharma must seize opportunities to promote innovation uptake.